Christopher Lagraize, MD
Vascular Surgery · Lafayette, LANPI 1164413381
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Boston Scientific at 45.0% of the total. 2025 is the largest year on record at $21,894, more than ten times the $1,205 reported in 2019. Among vascular surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $121.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$21K
- Silk Road Medical, Inc.$16K
- Endologix LLC$4K
- Medtronic$2K
- Shockwave Medical, Inc$484
- Angiodynamics, Inc.$378
- plus $4K from 37 others
Across 20 payments — averaging $1955.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$34K
- Boston Scientific$5K
What the payments were for
- Consulting fees$10,80023%
- Speaking & faculty fees$19,75042%
- Travel & lodging$3661%
- Food & beverage$15,72934%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 69 | $20,984 |
| Silk Road Medical, Inc. | 120 | $15,600 |
| Endologix LLC | 14 | $3,733 |
| Medtronic(2 entities) | 50 | $1,832 |
| Shockwave Medical, Inc | 12 | $484 |
| Angiodynamics, Inc. | 3 | $378 |
| Johnson & Johnson(2 entities) | 15 | $311 |
| Penumbra, Inc. | 4 | $298 |
| Cook Medical LLC | 10 | $237 |
| Philips North America LLC | 8 | $226 |
| Biom'up France SAS | 5 | $209 |
| Terumo Medical Corporation | 3 | $182 |
| Abiomed | 3 | $179 |
| Coloplast | 1 | $178 |
| Truvic Medical, Inc. | 3 | $168 |
| Kerecis Limited | 5 | $163 |
| Cardiovascular Systems Inc. | 3 | $147 |
| Venclose Inc. | 1 | $121 |
| Artivion, Inc. | 5 | $106 |
| Inari Medical, Inc. | 2 | $102 |
| Biocompatibles, Inc. | 2 | $89 |
| Atricure, Inc. | 2 | $82 |
| Avinger Inc. | 4 | $80 |
| Abbott | 4 | $72 |
| Baxter Healthcare | 1 | $70 |
| Organogenesis Inc. | 4 | $66 |
| Contego Medical, Inc | 1 | $47 |
| Smith+Nephew | 2 | $47 |
| Lemaitre Vascular, Inc. | 3 | $46 |
| Convatec Inc. | 2 | $44 |
| Surmodics, Inc. | 3 | $43 |
| BD | 2 | $38 |
| Bard Peripheral Vascular, Inc. | 2 | $36 |
| Sirtex Medical Inc | 2 | $36 |
| Cvrx, Inc. | 1 | $34 |
| Sanara Medtech Inc. | 3 | $29 |
| AstraZeneca | 2 | $27 |
| Argon Medical Devices, Inc. | 2 | $27 |
| Next Science LLC | 1 | $24 |
| Acell, Inc. | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $20 |
| KCI USA, Inc. | 1 | $17 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$35,605
- ENROUTE Transcarotid Stent$13,098
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$2,520
- Alto Abdominal Stent Graft System$2,426
- AFX2 Bifurcated Endograft System$921
- ENHANCE Transcarotid Peripheral Access Kit$522
- ENDURANT IIS$456
- Auryon Laser System 100-120 Vac$320
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$296
- ENROUTE .014 Guidewire$285
- Torus Stent Graft System$243
- ENDOCROSS Device$243
- ENROUTE Transcarotid Stent System$237
- ENROUTE 0.014 Guidewire$237
- TITAN$178
- HawkOne$176
- Indigo$167
- Penumbra Ruby Coil$167
- Valiant Captivia$149
- Impella$136
How this compares
$46,644 in reported general payments places this provider in the 90th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 77 | $44,223 |
| EliquisApixaban | 23 | $19,665 |
| ClopidogrelClopidogrel Bisulfate | 271 | $2,223 |
| Cilostazol | 44 | $959 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $733 |
| Atorvastatin Calcium | 39 | $213 |
| Gabapentin | 23 | $128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $311 | $44,22377 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 65 vascular surgery providers in Louisiana.
Other vascular surgery in Lafayette
- Allen BuiLafayette$19K
- Joshua SibilleLafayette$17K
- John LukeLafayette$7K
- Angelle HoganLafayette$6K
- Racheed GhanamiLafayette$5K
- Michael Conners IiiBaton Rouge$70K
- Gregory CrenshawMetairie$67K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- Paul PerkowskiShreveport$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.